This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Ishita Chatterjee: Innovator in Immunoglobulin Proteins
Introduction
Ishita Chatterjee is a prominent inventor based in Nanuet, NY (US). She has made significant contributions to the field of immunology through her innovative research and development of novel immunoglobulin proteins. Her work focuses on advancing medical science and improving patient outcomes.
Latest Patents
Ishita holds 1 patent for her invention titled "Immunoglobulin proteins that bind to NPR1 agonists." This patent provides a detailed disclosure of novel immunoglobulin proteins that specifically bind to a human natriuretic peptide receptor 1 (NPR1) agonist, particularly an anti-NPR1 antibody. The proteins described in her patent are designed to block and/or reverse the effects of administered anti-NPR1 antibodies. Furthermore, these antigen-binding proteins are aimed at effectively managing blood pressure and hemodynamics in humans.
Career Highlights
Ishita Chatterjee is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to push the boundaries of scientific research. Her work at Regeneron has allowed her to collaborate with leading experts in the field and contribute to groundbreaking advancements in immunology.
Collaborations
Some of her notable coworkers include Michael E. Dunn and Lori C. Morton. Their collaborative efforts have further enhanced the research environment at Regeneron, fostering innovation and creativity in the development of new therapeutic solutions.
Conclusion
Ishita Chatterjee is a remarkable inventor whose work in immunoglobulin proteins has the potential to transform medical treatments. Her dedication to research and innovation continues to pave the way for advancements in healthcare.